Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. by Mitchell, C, Richards, S, Kinsey, SE, Lilleyman, J, Vora, A, Eden, T

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. by Vora, A, Mitchell, C, Lennard, L, Eden, T, Kinsey, SE, Lilleyman, J, Richards, S

A comparison of Cox regression and neural networks for risk stratification in cases of acute lymphoblastic leukaemia in children. by Kinsey, SE, Groves, D, Smye, S, Richards, S, Chessells, J, Eden, O, Bailey, C

A comparison of Cox Regression and neural networks for risk stratification in cases of acute lymphoblastic leukaemia in children by Groves, D, Smye, S, Kinsey, SE, Richards, S, Chessells, J, Eden, O, Bailey, C

Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97. by Lennard, L, Richards, S, Mitchell, C, Cartwright, C, Eden, T, Kinsey, SE, Lilleyman, J, Vora, A

Intraocular relapse of childhood acute lymphoblastic leukemia. by Somervaille, T, Hann, I, Harrison, G, Eden, T, Gibson, B, Hill, F, Mitchell, C, Kinsey, SE, Vora, A

Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97. by Moor-Man, A, Ensor, H, Chilton, L, Richards, S, Kinsey, SE, Vora, A, Mitchell, C, Harrison, C

Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council... by Krishnan, S, Wade, R, Moorman, A, Mitchell, C, Kinsey, SE, Eden, T, Parker, C, Vora, A, Richards, S, Saha, V

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. by Moorman, A, Ensor, H, Richards, S, Chilton, L, Schwab, C, Kinsey, SE, Vora, A, Mitchell, C, Harrison, C

Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). by Moorman, A, Richards, S, Robinson, H, Strefford, J, Gibson, B, Kinsey, SE, Eden, T, Vora, A, Mitchell, C, Harrison, C

Intraocular relapse of childhood acute lymphoblastic leukaemia. by Somervaille, T, Hann, I, Harrison, G, Eden, T, Gibson, B, Hill, F, Mitchell, C, Kinsey, SE, Vora, A, Lilleyman, J

Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor. by Enshaei, A, Schwab, C, Konn, Z, Mitchell, C, Kinsey, SE, Wade, R, Vora, A, Harrison, C, Moorman, A

Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor by Enshaei, A, Schwab, C, Konn, Z, Mitchell, C, Kinsey, SE, Wade, R, Vora, A, Harrison, C, Moorman, A

Acute lymphoblastic leukaemia has a poor outcome in children with Down syndrome due to infective death in remission - (Results of UK MRC ALL 97 trial). by de la Fuente, J, Richards, S, Webb, D, Hann, I, Mitchell, C, Vora, A, Kinsey, SE, Eden, O, Ancliff, P, Working, U

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial. by Ensor, H, Schwab, C, Russell, L, Richards, S, Morrison, H, Masic, D, Jones, L, Kinsey, SE, Vora, A, Mitchell, C, Harrison, C, Moorman, A

Genome-wide homozygosity signatures and childhood acute lymphoblastic leukemia risk. by Hosking, F, Papaemmanuil, E, Sheridan, E, Kinsey, SE, Lightfoot, T, Roman, E, Irving, J, Allan, J, Taylor, M, Tomlinson, I, Greaves, M, Houlston, R

Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia by Enciso-Mora, V, Hosking, F, Sheridan, E, Kinsey, SE, Lightfoot, T, Roman, E, Irving, J, Tomlinson, I, Allan, J, Taylor, M, Greaves, M, Houlston, R

Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia. by Enciso-Mora, V, Hosking, F, Sheridan, E, Kinsey, SE, Lightfoot, T, Roman, E, Irving, J, Tomlinson, I, Allan, J, Taylor, M, Greaves, M, Houlston, R

The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6-RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL) by Moorman, A, Konn, Z, Barber, K, Wright, S, Stewart, A, Parker, H, Richards, S, Kinsey, SE, Eden, O, Vora, A, Mitchell, C, Strefford, J, Harrison, C

A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia. by Moorman, A, Enshaei, A, Schwab, C, Wade, R, Chilton, L, Elliott, A, Richardson, S, Hancock, J, Kinsey, SE, Mitchell, C, Goulden, N, Vora, A, Harrison, C